AXA Venture Partners

AXA Venture Partners (AVP) is a global venture capital firm backed by the AXA Group, managing over $2 billion in assets under management. The firm invests in high-growth, technology-enabled companies across North America and Europe, with a significant focus on healthcare, enterprise software, fintech, and consumer technologies. Within the life sciences and healthcare sectors, AVP targets digital health platforms, medical technology, and innovative biotech companies that improve clinical outcomes and operational efficiency. AVP provides capital and strategic support across the entire business lifecycle, from early-stage venture capital to late-stage growth equity. By leveraging AXA's global network, the firm offers its portfolio companies unique market access and strategic expertise to scale internationally.